A new feature “generally useless". In an article fromWashington Post, Geoffrey A. Fowler pulls no punches. According to him,the new optionmonitoring of blood oxygen levels offered on the Apple Watch Series 6 and its competitor, the Fitbit Sense, has very serious limitations.
No Food and Drug Administration approval
He is not the only one to think so and several experts explain in particular that the new system does not have the same reliability as those used in a medical setting. Concretely, these measure oxygen levels at your fingertips. These are filled with small blood vessels, which improves reading. Conversely, the Apple Watch Series 6 sensor performs its evaluation from the wrist, which has fewer capillaries, and this makes the estimation less reliable.
As recallediDropNews, Apple executives touted the merits of their new feature. “Another valuable health metric for users", according to Sumbul Ahmad Desai, the company's vice president for health. However, the company seems less enthusiastic on its site. It is notably specified that the measurement of the oxygen level in the blood is not “intended for medical use" more "designed for general fitness and wellness purposes only».
Moreover, Apple has not submitted its sensor to the Food and Drug Administration and therefore cannot obtain its approval as is the case for thefonction ECGde l’Apple Watch.
i-nfo.fr - Official iPhon.fr app
By : Keleops AG
